European Hematology Association - 31st Congress, 2026 (EHA) 11 - 14 June 2026

Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study

Authors :

Sujit Sheth¹; Kevin H. M. Kuo^{2, 3}; Theodosia A. Kalfa⁴; D. Mark Layton⁵; Perla Eleftheriou⁶; Anastasios Giakoumis⁷; Olga Polyanskaya⁸; Navid Nedjatian⁹; Ashutosh Lal¹⁰

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Thalassemia

Congress oral presentation

Etavopivat

Search Science Hub

Are you a healthcare professional?

Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study